Size: 60 Chewable Tablets

• For Intestinal and Immune Health
• Great For Kids, Yummy Taste
• Sugar-Free. No Artificial Sweetener, Flavor or Color
• Each Tablet is Individually Blister Packed for Enhanced Stability and Convenience

Jarrow Formulas Yum-Yum Dophilus provides 4 strains of potent beneficial bacteria in a yummy chewable tablet. Beneficial intestinal flora can be depleted by a diet that is low in fiber, high in meat and sugar, by medication taken for illness and infections, by travel and by stress and other factors.The result is the disruption of the normal intestinal microflora, which can affect digestion and well being. The friendly bacteria in Yum-Yum Dophilus favorably balance the microorganisms in the intestines, support immune function and promote health. Xylitol is used to enhance the taste and promote dental health. Sugar-Free. No artificial sweetener, flavor or color.Each tablet is individually blister packed for enhanced stability and convenience.

Suggested Use: Children 2 years and above: Chew 2 tablets 30 minutes after a meal or on an empty stomach followed by 1/2 glass of water 20 minutes before eating, or as directed by your qualified health care consultant. Recommended for children age 2 and above taken under the supervision of a parent or caregiver. Keep Refrigerated. Vegetarian Product.

SUPPLEMENT FACTS
Serving Size: 2 Chewable Tablets
Servings Per Container: 30
Amount Per Serving / %DV
Probiotic Bacteria – 1 billion / *
L. acidophilus LA-14
B.bifidum BB-02
L.plantarum LP-115
B. lactis BL-04
Inulin-FOS (FructoOligoSaccharides) – 100mg / *
*Daily Value (DV) not established.

Other Ingredients: Xylitol, beet juice powder, natural raspberry flavor, citric acid, magnesium stearate (vegetable source) and MogroPure (Lo Han fruit extract, Momordica grosvenorii).

Contains: Soy and milk (in trace amounts).

No wheat, no gluten, no egg, no fish/shellfish, no peanuts/tree nuts.

At time of manufacture, 2 chewable tablets contains a minimum of 1 billion organisms.

1. Gorbach SL. Probiotics and gastrointestinal health. Am J Gastroenterol 2000; 95(suppl):S2-S4.
2. Hoyos AB. Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis 1999; 3:197-2.
3.Araya-Kojima T, Yaeshima T, Ishibashi N, Shimamura S and Hayasawa H. (1995). Inhibitory effects of Bifidobacterium longum BB536 on harmful intestinal bacteria. Bifidobacteria and Microflora. 14(2), 59-66.
4. Yoshioka H, Fujita K, Sakata H, Murono K & Iseki K. (1991). Development of the normal intestinal flora and its clinical significance in infants and children. Bifidobacteria and Microflora 10(1) 11-17.

Image and text supplied courtesy of Jarrow FORMULAS, all rights reserved.